In a bid to transform corporate America, a new nonprofit created by a Wall Street hedge fund manager has ranked nearly 1,000 publicly traded companies to determine the extent to which they pursue “just” policies and practices. And leading the pack among drug makers is Amgen.
The goal is to maintain an information clearinghouse that can be used to spur companies to make improvements while, at the same time, giving the public tools to make more informed decisions about purchasing, investing, and employment.
